ADMS Forecast and Technical Stock AnalysisSell candidate since 2019-07-19
Adamas Pharmaceuticals fell by -0.50% in the last day ( Friday, 19th Jul 2019 ) from $6.03 to $6.00 During day the stock fluctuated 2.69% from a day low at $5.94 to a day high of $6.10. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume has increased in the last day by 38 681 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 220 736 shares bought and sold for approximately $1.32 million.
- 30 day high of the ADMS stock price was $6.36 and low was $4.93.
- 90 day high was $6.53 and low was $4.20.
- 52 week high for the Adamas Pharmaceuticals - $29.49 and low - $4.20.
Adamas Pharmaceuticals lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $6.17 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -4.52% during the next 3 months and, with 90% probability hold a price between $3.97 and $5.89 at the end of this period.
Adamas Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $5.99 and $5.43. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday July 18, 2019, which indicates further falls until a new bottom pivot has been found. Adamas Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 42 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Support & Resistance
Adamas Pharmaceuticals finds support from accumulated volume at $5.96.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.16 (2.69%) between high and low. For the last week, the stock has had a daily average volatility of 3.21%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
3.21 %Average volatility
Very Low Low Medium High Very High
Adamas Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.
|ADMS $6.00 ($-0.03 -0.50%)|
ADMS is down $0.03 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ADMS based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ADMS analysis is free »
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now